This inventor holds 4 USPTO granted patents. Top assignees: Incon-Trol Corp., Spacelabs, Inc.. Active years: 1991-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991-1997
Title: Innovations by Craig S. Siegman
Introduction
Craig S. Siegman is an accomplished inventor based in Redmond, WA (US). He has made significant contributions to the field of medical devices, particularly in cardiac technology. With a total of 4 patents to his name, Siegman's work has the potential to improve patient outcomes in cardiac care.
Latest Patents
One of Siegman's latest patents is a "System and method for implanting an implantable cardiac device." This innovative system includes an external device that emulates the operation of the implantable cardiac device, allowing for precise implantation. The external programmer transmits operating parameters to the implantable device, ensuring accurate functionality post-implantation. Another notable patent is for an "Implantable atrial defibrillator and system having multiple channels." This defibrillator system features both implantable and non-implantable components, enabling the simultaneous display of electrograms for better monitoring of cardiac events.
Career Highlights
Throughout his career, Craig S. Siegman has worked with reputable companies such as Incon-Trol Corporation and Spacelabs, Inc. His experience in these organizations has contributed to his expertise in developing advanced medical technologies.
Collaborations
Siegman has collaborated with notable professionals in the field, including Joseph M. Bocek and Paul E. deCoriolis. These partnerships have likely enhanced his innovative capabilities and broadened the impact of his inventions.
Conclusion
Craig S. Siegman's contributions to cardiac technology through his patents and collaborations highlight his role as a significant innovator in the medical device industry. His work continues to pave the way for advancements in patient care and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
